Abstract:Seven-transmembrane receptors, also called GPCRs, represent the largest class of drug targets. Upon ligand binding, a GPCR undergoes conformational rearrangement and thereby changes its interaction with effector proteins including the cognate G-proteins and the multifunctional adaptor proteins, β-arrestins. These proteins, by initiating distinct signal transduction mechanisms, mediate one or several functional responses. Recently, the concept of ligand-directed GPCR signalling, also called functional selectivity or biased agonism, has been proposed to explain the phenomenon that chemically diverse ligands exhibit different efficacies towards the different signalling pathways of a single GPCR, and thereby act as functionally selective or 'biased' ligands. Current concepts support the notion that ligand-specific GPCR conformations are the basis of ligand-directed signalling. Multiple studies using fluorescence spectroscopy, X-ray crystallography, mass spectroscopy, nuclear magnetic resonance spectroscopy, single-molecule force spectroscopy and other techniques have provided the evidence to support this notion. It is anticipated that these techniques will ultimately help elucidate the structural basis of ligand-directed GPCR signalling at a precision meaningful for structure-based drug design and how a specific ligand molecular structure induces a unique receptor conformation leading to biased signalling. In this review, we will summarize recent advances in experimental techniques applied in the study of functionally selective GPCR conformations and breakthrough data obtained in these studies particularly those of the β2-adrenoceptor.

Mechanisms of signalling and biased agonism in G protein-coupled receptors

Molecular mechanism of biased signaling in a prototypical G protein–coupled receptor

Progress on the development of Class A GPCR‐biased ligands

[Research Progress in Signal Bias of G Protein-Coupled Receptor and Its Mechanism].

Molecular Mechanisms of GPCR Signaling: A Structural Perspective

Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation

Structure, function and drug discovery of GPCR signaling

Molecular determinants of ligand efficacy and potency in GPCR signaling

Signalling bias in new drug discovery: detection, quantification and therapeutic impact

Discovery of GPCR ligands for probing signal transduction pathways

Exploring Bias in GPCR Signaling and its Implication in Drug Development: A One-Sided Affair

G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery

Essential Dynamics of CB Receptor-Agonist Complexes: Implications for Signalling Bias

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Advances in Receptor Conformation Research: the Quest for Functionally Selective Conformations Focusing on the Β2-Adrenoceptor.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

The role of structural dynamics in GPCR‐mediated signaling

GPCR oligomers in pharmacology and signaling

Flavors of GPCR signaling bias

Exploring Diverse Signaling Mechanisms of G Protein-Coupled Receptors through Structural Biology

Multiple Ligand-Specific Conformations of the Β2-Adrenergic Receptor